A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia

This study has been completed.

Study NCT00008840 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: January 18, 2001 Last Updated: November 9, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	November 2005
Estimated Primary Completion Date:	No date given